Research article summary (published 13 Oct 2009):

Parity and age at first childbirth in relation to the risk of different breast cancer subgroups.

Full Abstract

The aim of the present study was to examine parity and age at first childbirth, in relation to the risk of specific breast cancer subgroups. A prospective cohort, The Malmö Diet and Cancer Study, including 17,035 women were followed with linkage to Swedish Cancer Registry until December 31, 2004. A total of 622 incident breast cancers were diagnosed during follow-up and were evaluated regarding invasiveness, tumour size, axillary lymph node status, Nottingham grade, tumour proliferation (Ki67), HER2, cyclin D1 and p27. The tumours were also examined for WHO type and hormone receptor status. Nulliparity was associated with an overall increased risk of breast cancer, although not statistically significant (the relative risk was 1.39 with a 95% confidence interval of 0.92-2.08). Nulliparity was also associated with large tumours (>20 mm) (1.89: 0.91-3.91), high Ki67 levels (1.95: 0.93-4.10), high cyclin D1 levels (2.15: 0.88-5.27), grade III (2.93: 1.29-6.64) and HER2 positive tumours (3.24: 1.02-10.25). High parity was not statistically significantly associated with any specific breast cancer subgroup. Older age at first childbirth (>30) was associated with a slightly increased risk of breast cancer (1.39: 0.94-2.07). There was a statistically significant association between late first childbirth and lobular type (2.51: 1.01-6.28), grade III tumours (2.67: 1.19-6.02), high levels of cyclin D1 (2.69: 1.18-6.12) and low levels of p27 (2.23: 1.15-4.35). We conclude that nulliparity and late first childbirth are associated with relatively more aggressive breast cancer subgroups.

Author information

Author/s: Butt, Salma (S); Borgquist, Signe (S); Anagnostaki, Lola (L); Landberg, Göran (G); Manjer, Jonas (J);

Affiliation: Department of Surgery, Malmö University Hospital, 205 02 Malmö, Sweden. Salma.Butt(-atsign-)med.lu.se

Journal and publication information

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal: International journal of cancer. Journal international du cancer (Int J Cancer), published in United States. (Language: eng)

Reference: 2009-Oct; vol 125 (issue 8) : pp 1926-34

Dates: Created 2009/08/26; Completed 2009/09/21;

PMID: 19569233, status: MEDLINE (last retrieval date: 9/21/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Adult Age Factors Breast Neoplasms - classification; metabolism; pathology Carcinoma in Situ - metabolism; pathology Carcinoma, Lobular - metabolism; pathology Cell Proliferation Cyclin D1 - metabolism Estrogen Replacement Therapy Female Follow-Up Studies Humans Lymph Nodes - pathology Lymphatic Metastasis

Lymphatic Metastasis Menopause Middle Aged Neoplasm Invasiveness Parity Pregnancy Prognosis Prospective Studies Receptor, erbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism Risk Factors Young Adult

Associated Chemicals: CCND1 protein, human (0) ; HER2 protein, human (0) ; Receptors, Estrogen (0) ; Receptors, Progesterone (0) ; Cyclin D1 (136601-57-5) ; Receptor, erbB-2 (EC 2.7.1.112)

Related articles

These are the highest related articles currently in the database:

• p95HER-2 predicts worse outcome in patients with HER-2-positive breast cancer. 13 Jan 2006
• Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. 30 Jan 2004
• Atypical lobular hyperplasia and lobular carcinoma in situ: surgical and molecular pathology. 30 Aug 1999
• p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. 30 Dec 1996
• Role of E-cadherins in development of lymphatic tumor emboli. 29 Apr 2003
• Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer. 30 Dec 1999
• Immunohistochemical analysis of prostate specific antigen in breast cancer. 29 Jun 2001
• Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast. 29 Apr 2003
• The hyperplasia-to-carcinoma sequence in the breast. Immunohistochemical-histologic correlations. 30 May 2000
• Bilateral paget disease of the nipple associated with lobular carcinoma in situ. 30 Dec 2001

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.